Search Orphan Drug Designations and Approvals
-
| Generic Name: | Ifosfamide | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | Ifex | ||||||||||||||||
| Date Designated: | 01/20/1987 | ||||||||||||||||
| Orphan Designation: | Treatment of testicular cancer. | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Bristol-Myers Squibb Pharmaceutical Research Institute 5 Research Parkway, P.O. Box 5100 Wallingford, Connecticut 06492 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | Ifosfamide |
|---|---|---|
| Trade Name: | Ifex | |
| Marketing Approval Date: | 12/30/1988 | |
| Approved Labeled Indication: | In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer. | |
| Exclusivity End Date: | 12/30/1995 | |
| Exclusivity Protected Indication* : | ||
-
